Free

Eliminating hepatitis C in prisons: Lessons from the SToP-C study

Actions and Detail Panel

Free

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
For World Hepatitis Day, we’ll hear from experts about the evidence that treatment as prevention in prisons works

About this event

Eliminating hepatitis C in prisons will be a crucial setting if World Health Organization (WHO) elimination targets are to be achieved. For World Hepatitis Day, we’ll hear from experts about the evidence that treatment as prevention in prisons works, and how it can be rolled out in Australia to have the most effective impact. Drawing on findings from the Surveillance and treatment of prisoners with hepatitis C (SToP-C) study, the panel will also discuss the importance of integration with drug dependence management.

The webinar is presented through the ASCEND program grant (Advancing the health or people who use drugs: hepatitis C and drug dependence), a collaboration between UNSW Sydney’s Kirby Institute and National Drug and Alcohol Research Centre (NDARC), funded by the National Health and Medical Research Centre.

Chaired by:

With presentations:

  • Dr Behzad Hajarizadeh, Senior Lecturer, Kirby Institute. Hepatitis C treatment-as-prevention in the prison setting: The SToP-C Study
  • Dr Lise Lafferty, Research Fellow, Kirby Institute. Perceptions and concerns of hepatitis C reinfection within the prison setting
  • Professor Andrew Lloyd, Program Head, Kirby Institute. A guide to scale-up of testing and treatment in prisons: the SToP-C Implementation Toolkit
  • Professor Adrian Dunlop, Director, Drug and Alcohol Clinical Services, Hunter New England Local Health District. Understanding NSW long-acting opioids in custody: the UNLOC-T study

Followed by a panel discussion and Q&A session.

For full speaker bios and panellist list, please see event page.


		Eliminating hepatitis C in prisons: Lessons from the SToP-C study image
Share with friends

Date and time

Location

Online event

{ _('Organizer Image')}

Organiser Kirby Institute

Organiser of Eliminating hepatitis C in prisons: Lessons from the SToP-C study

The Kirby Institute is a leading global research institute dedicated to the prevention and treatment of infectious diseases, with a particular focus on HIV, viral hepatitis and sexually transmissible infections. Our research is undertaken across a spectrum that ranges from laboratory studies, through clinical trials of preventative and therapeutic treatments, to public health surveillance and impact evaluation.

Save This Event

Event Saved